The Milbank quarterly
-
The Milbank quarterly · Dec 2009
Comparative StudyExpensive cancer drugs: a comparison between the United States and the United Kingdom.
This article compares the United Kingdom's and the United States' experiences with expensive cancer drugs to illustrate the challenges posed by new, extremely costly, medical technologies. ⋯ Key elements of the British system are fairer than the American system, and the British system is better structured to deal with difficult decisions about expensive end-of-life cancer drugs. Both systems face common ethical, financial, organizational, and priority-setting challenges in making these decisions.